MULTIPLE SCLEROSIS, RELAPSING-REMITTING

This study aims to see if a newer oral medication called ozanimod works as well as or better than an existing drug, fingolimod, for controlling multiple sclerosis in children and adolescents. About 194 young people with relapsing-remitting MS will take one of the two daily pills …

This study is testing whether clemastine fumarate, an over-the-counter allergy medication, can repair the protective myelin coating around nerves in people with multiple sclerosis (MS). Researchers will use advanced MRI brain scans to measure changes in myelin in 74 participants …

This study is testing a special training program designed to help people with multiple sclerosis (MS) avoid dangerous falls. Researchers want to see if repeatedly practicing how to recover from slips and trips on a treadmill can teach the body new, safer movement skills. The goal…

This study is testing a breathing treatment called Acute Intermittent Hypoxia (AIH) to see if it can improve arm and hand function in people with multiple sclerosis (MS). Participants will breathe brief periods of low oxygen, which has been shown in early research to safely incre…

This study is testing a wearable device called the Cionic Neural Sleeve to see if it can help people with MS walk better and be more active. Fourteen participants will wear the sleeve on one leg for six weeks while following a walking program. Researchers will measure changes in …

This study is testing whether breathing short bursts of low-oxygen air, similar to the air on a tall mountain, can improve ankle strength in people with multiple sclerosis (MS). Researchers will measure participants' strength and brain activity before and after the breathing sess…

This study is testing whether a non-invasive brain stimulation technique can reduce the severe fatigue commonly experienced by people with multiple sclerosis (MS). Researchers will use a device called repetitive Transcranial Magnetic Stimulation (rTMS) to deliver magnetic pulses …

This study aims to better understand how multiple sclerosis (MS) starts and progresses by collecting detailed health data from about 100 patients in Switzerland. Participants will use a smartphone app to track symptoms and complete regular tests, while researchers analyze this in…